Learn More
Medchemexpress LLC N-(3-((3-(5-chlorothiophene-2-sulfonamido)-4-methoxyindazol-1-yl)methyl)benzyl)-2-hydroxy-2-methylpropanamide | 1240516-71-5 | 99.8% | 549.06 | C24H25ClN4O5S2 | 25 MG

Supplier: Medchemexpress LLC HY10018325MG
GSK2239633A is a small-molecule CC-chemokine receptor 4 (CCR4) antagonist supplied for research use. It inhibits [125I]-TARC binding to human CCR4 with a reported pIC50 of 7.96 and shows activity in human CD4+ CCR4+ T-cells. The compound is provided as a solid with high reported purity and defined molecular formula and weight, suitable for in vitro pharmacology and analytical studies.
- Allosteric CCR4 antagonist with reported pIC50 ~7.96.
- Validated in vitro activity on human CD4+ CCR4+ T-cells.
- High reported purity suitable for research assays.
- Solid form, stable for analytical use.
- Contains defined molecular formula and molecular weight for characterization.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.